Innovative Funding Models for Treatment of Cancer and Other High-Cost Chronic Noncommunicable Diseases
White Paper
Sep 06, 2019
A global landscape study of funding trends and innovations

The cost of cancer and high-cost chronic noncommunicable diseases (NCDs) are significant and growing, posing an increasingly high burden of disease to health systems, businesses and individuals. Optimal patient outcomes are fundamentally linked to affordability and, despite meaningful efforts within the health system, current traditional funding models will struggle to close the funding gap.

This global landscape study identifies and assesses innovative funding models for cancer and other high-cost chronic NCDs across Africa, Asia, Europe, Latin America and Middle East. The study aims to enable readers to better understand the possibilities of innovative funding while stressing the key success factors that enable sustainability and success, such as stakeholder collaboration.

Contact Us
Contact Us

Email Us

Get in touch today to discover the right solutions for you.

Call Us

We are pleased to speak with you during our standard business hours.

U.S. Toll-Free only
+1 866 267 4479

For international call please find a number in our toll-free list.